GLP-1SG is studied in laboratory models of GLP-1 receptor pharmacology, incretin signaling, and metabolic pathways.
- GLP-1 receptor pharmacology
- Incretin signaling
- Metabolic pathway models
GLP-1SG is the catalog name for this GLP-1 receptor peptide
The public name is GLP-1SG. Papers may say semaglutide. The listing is one receptor family, not the dual listing GLP-2TZ and not the three-receptor listing GLP-RT3.
Task 155227, batch Sema-15, May 27, 2026, prints GLP-1SG 15.23% and purity 99.262%. Do not convert 15.23% to milligrams.
Price and the neighboring vials
This vial is $54.99 for a 15 mg label. GLP-2TZ 15 mg is $64.99. GLP-RT3 20 mg is $84.99. Each has its own task number.
This page is laboratory education for adults 21 and older. It is not a dosing guide, a treatment plan, or a ranking of which material to use. Not for human or veterinary use.
GLP-1SG 15 mg research questions
What unit is 15.23%?
A percent, as printed on task 155227. It is not a milligram result.
What name is on the vial?
GLP-1SG.
References and further reading
- PubMed literature index — GLP-1SG 15 mg ↗
A continuously updated index of peer-reviewed biomedical literature. Study quality, model, and relevance must be assessed individually.
- FDA — Analytical Procedures and Methods Validation ↗
Regulatory guidance on analytical method development and validation.
- ICH Q2(R2) — Validation of Analytical Procedures ↗
International guidance on specificity, accuracy, precision, range, and robustness.
- Hoofnagle et al. — Recommendations for peptide storage and handling ↗
Peer-reviewed recommendations for peptide handling in quantitative laboratory workflows.
External links are provided for independent literature review. A link does not imply that every indexed paper supports the same conclusion or that findings apply beyond the model and conditions studied.
